Invech Holdings, Inc. IVHI

Q2 FY2026 · ended Jun 30, 2026 · Revenue $0 · Filed Aug 21, 2026

Invech Holdings, Inc. (IVHI) files with the SEC under industry code 8742, Services-Management Consulting Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $0 and a net loss of $83,426.

Revenue
$0
Net income
$-83,426
-1011.9% vs year-ago quarter
Operating cash flow
$-39,692
-429.0% vs year-ago quarter
Free cash flow
—
EPS
$-0.00
+0.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
106.70M
+6.1% vs year-ago quarter
Net cash
—
Operating margin
—

Company profile

Industry
Services-Management Consulting Services (SIC 8742)
Listed as
IVHI (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Las Vegas, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1009919
Former names
Amersin Life Sciences CORP (until Aug 2, 2006); HUBEI PHARMACEUTICAL GROUP LTD (until Jan 31, 2005); PAN ASIA COMMUNICATIONS CORP (until Mar 20, 2003); EXPLORE TECHNOLOGIES INC (until Jun 25, 2002)

Other Services-Management Consulting Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$0
$0
$0
$0
$0
Operating income
-$71,146
-$119,313
-$10,061
-$9,077
-$7,503
Net income
-$83,426
-$119,313
-$10,061
-$9,077
-$7,503
Diluted EPS
-$0.00
$0.00
-$0.00
$0.00
-$0.00
Operating cash flow
-$39,692
-$39,500
-$7,811
-$11,327
-$7,503
Total assets
$282,280
$517,600
$1,500
$3,750
$1,500
Total liabilities
$54,944
$507,827
$63,649
$55,838
$48,954
Stockholders' equity
$227,336
$9,773
-$62,149
-$52,088
-$47,454
Cash and investments
$46
$100
$0
$0
$0

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Change in control, Officer or director change
Sep 15, 2026 Aug 10, 2026
10-Q/A Amended quarterly report Aug 21, 2026 Jun 30, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Change in control, Officer or director change
Aug 3, 2026 Jul 17, 2026
8-K/A Amended current report
Material agreement, Acquisition or sale of assets
Jun 4, 2026 Mar 3, 2026
8-K Current report
Material agreement
Jun 4, 2026 Jun 1, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.